EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Keratocan Improves Muscle Wasting in Sarcopenia by Promoting Skeletal Muscle Development and Fast‐Twitch Fibre Synthesis

Xu Chen, Yanyan Zhang, Zhibo Deng, Chao Song, Linhai Yang, Rongsheng Zhang, Peng Zhang, Yu Xiu, Yibin Su, Jun Luo, Jie Xu, Hanhao Dai

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.13724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Xu Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Sarcopenia, Muscle, Skeletal, Muscle Development, Muscle Fibers, Fast-Twitch. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Provincial Natural Science Foundation Projects, Flint Fund project, Medical Innovation Project of Fujian Provincial Health Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteosarcopenia refers to the co‐occurrence of osteoporosis and sarcopenia, which are characterized by progressive bone density and muscle mass loss, respectively. Muscle and bone are regulated by many common genes and pathways, enabling potential co‐treatment. Because keratocan protects against osteoporosis, we hypothesized it may also protect against sarcopenia, implying a new co‐intervention target. This study aimed to elucidate the role and molecular mechanisms of keratocan in skeletal muscle.

Methods

We analysed keratocan expression in the muscles of aged mice and patients with osteosarcopenia and during the differentiation of C2C12 myoblasts. The regulatory role of keratocan was assessed by knocking down or overexpressing keratocan in C2C12 cells and examining any effects on myogenic proliferation and differentiation. RNA sequencing analysis was also performed on these cells. The relationship between keratocan and enriched signalling pathways was verified using pathway inhibitors or agonists. Finally, adeno‐associated virus‐9 containing a muscle‐specific promoter was injected into SAMP8 senile mice to observe the effects of keratocan overexpression.

Results

Keratocan expression was significantly lower in the skeletal muscles of aging mice (−2.02‐fold, p < 0.01) and patients with osteosarcopenia (−1.78‐fold, p < 0.001) compared with that in controls. Keratocan overexpression resulted in a significant increase in the proliferation indices CCND1 (+1.43‐fold, p < 0.001), Ki67 (+2.30‐fold, p < 0.001) and PCNA (+1.975‐fold, p < 0.01) and the differentiation indices MyoD1 (+2.156‐fold, p < 0.001), MyoG (+1.52‐fold, p < 0.05) and myosin heavy chain (MyHC; +2.849‐fold, p < 0.01); conversely, the muscle atrophy indices MuRF‐1 (−30%, p < 0.01), atrogin‐1 (−87%, p < 0.01) and myostatin (−24%, p < 0.01) were significantly decreased. PI3K/AKT/mTOR was identified as a potential pathway for keratocan regulation in C2C12 cells. PI3K inhibitor LY294002 reversed the promotion of myogenesis by keratocan overexpression, while PI3K activator 740Y‐P reversed the inhibitory effect of keratocan knockdown on myogenesis, promoting myofibre development and ameliorating muscle atrophy in SAMP8 aging mice. This was evidenced by increased mean muscle cross‐sectional area (+38%, p < 0.0001) and muscle mass (+7%, p < 0.01) and decreased fibrosis (−40%, p < 0.01). Furthermore, keratocan facilitated the conversion of slow‐to‐fast muscle fibres through the PI3K/AKT/mTOR pathway, characterized by significantly increased grip strength (+42%, p < 0.01) and maximum running speed (+19%, p < 0.001), and decreased fatigue time (+13%, p < 0.05).

Conclusions

Keratocan ameliorates muscle atrophy by activating the PI3K/AKT/mTOR pathway, promoting muscle satellite cell proliferation and myogenic differentiation, and facilitating the conversion of slow‐to‐fast muscle fibres. Our findings demonstrate the potential of keratocan as a novel therapeutic target for osteosarcopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaMuscle, SkeletalMuscle DevelopmentMuscle Fibers, Fast-TwitchMuscular AtrophyAnimalsMiceHumansMaleCell DifferentiationSignal Transduction

Stichwörter der Autor:innen

PI3K/AKT/mTOR pathwaykeratocanosteoporosisosteosarcopeniasarcopenia

Autor:innen und Institutionen

  • Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
  • Department of Minimally Invasive Spinal Surgery, The Affiliated Hospital of Putian University, Putian, China.
  • Department of Clinical Laboratory, The Affiliated Hospital of Putian University, Putian, China.
  • Department of Orthopedics, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
  • College of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China.

Förderung

  • Fujian Provincial Natural Science Foundation Projects
  • Flint Fund project
  • Medical Innovation Project of Fujian Provincial Health Department
  • National Key Clinical Specialty
  • Major Scientific Research Project of Fujian Province
  • Joint Funding Project of Science and Technology Innovation in Healthcare in Putian City
  • National Key Clinical Specialty Discipline Construction Program of China

Zitieren

APA

Chen, X., Zhang, Y., Deng, Z., Song, C., Yang, L., Zhang, R., Zhang, P., Xiu, Y., Su, Y., Luo, J., Xu, J., & Dai, H. (2025). Keratocan Improves Muscle Wasting in Sarcopenia by Promoting Skeletal Muscle Development and Fast‐Twitch Fibre Synthesis. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13724

Vancouver

Chen X, Zhang Y, Deng Z, Song C, Yang L, Zhang R, et al. Keratocan Improves Muscle Wasting in Sarcopenia by Promoting Skeletal Muscle Development and Fast‐Twitch Fibre Synthesis. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13724

BibTeX
@article{Chen2025,
  author = {Chen, Xu and Zhang, Yanyan and Deng, Zhibo and Song, Chao and Yang, Linhai and Zhang, Rongsheng and Zhang, Peng and Xiu, Yu and Su, Yibin and Luo, Jun and Xu, Jie and Dai, Hanhao},
  title = {Keratocan Improves Muscle Wasting in Sarcopenia by Promoting Skeletal Muscle Development and Fast‐Twitch Fibre Synthesis},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.13724}
}
Kostenlos starten →